Celldex Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Celldex Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Celldex Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 66.3M shares, a 40.4% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 66.3M +19.1M +40.4% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 66.3M +19M +40.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 65.9M +18.7M +39.5% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 55.9M +8.68M +18.4% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 47.3M +168K +0.36% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 47.3M +489K +1.05% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 47.2M +490K +1.05% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 47.2M +470K +1.01% Dec 31, 2022 10-K 2024-02-26
Q3 2022 47.1M +433K +0.93% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 46.8M +7.15M +18% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 46.8M +7.14M +18% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 46.7M +7.13M +18% Dec 31, 2021 10-K 2023-02-28
Q3 2021 46.7M +7.1M +17.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 39.6M +523K +1.34% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 39.6M +21.9M +123% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 39.6M +22.6M +133% Dec 31, 2020 10-K 2022-02-28
Q3 2020 39.6M +23.7M +149% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 39.1M +24.3M +164% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 17.7M +4.89M +38% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 17M +5.01M +41.9% Dec 31, 2019 10-K 2021-03-29
Q3 2019 15.9M -153M -90.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 14.8M -142M -90.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 12.8M -131M -91% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 12M +2.72M +29.5% Dec 31, 2018 10-K 2020-03-26
Q3 2018 169M +36.5M +27.6% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 157M +29.2M +22.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 143M +19.2M +15.5% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 9.23M -111M -92.3% Dec 31, 2017 10-K 2019-03-07
Q3 2017 132M +30.9M +30.5% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 127M +28M +28.2% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 124M +25.5M +25.8% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 121M +21.8M +22.1% Dec 31, 2016 10-K 2018-03-07
Q3 2016 101M +2.6M +2.64% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 99.4M +846K +0.86% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 98.7M +238K +0.24% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 98.7M +9.09M +10.1% Dec 31, 2015 10-K 2017-03-14
Q3 2015 98.6M +9.21M +10.3% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 98.5M +9.15M +10.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 98.5M +9.12M +10.2% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 89.6M +346K +0.39% Dec 31, 2014 10-K/A 2016-02-25
Q3 2014 89.4M +8.33M +10.3% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 89.4M +8.42M +10.4% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 89.4M +8.49M +10.5% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 89.2M +24.9M +38.7% Dec 31, 2013 10-K 2015-02-24
Q3 2013 81.1M +20.3M +33.4% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 81M +22.2M +37.8% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 80.9M +22.1M +37.7% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 64.4M +20.1M +45.6% Dec 31, 2012 10-K 2014-03-03
Q3 2012 60.8M +16.7M +37.7% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 58.8M +14.6M +33.1% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 58.7M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 44.2M +12.2M +37.9% Dec 31, 2011 10-K 2013-03-08
Q3 2011 44.1M Sep 30, 2011 10-Q 2011-11-03
Q2 2011 44.1M Jun 30, 2011 10-Q 2011-08-04
Q4 2010 32.1M Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.